Georgia Patent of the Month – January 2025
In the rapidly evolving field of medical diagnostics, MetGen has introduced a breakthrough invention: a handheld Surface-Enhanced Raman Spectroscopy (SERS) device designed for rapid biomarker detection. This compact device, measuring less than 100 mm in length and 80 mm in width, brings cutting-edge spectroscopy technology to the palm of the user, enabling convenient at-home testing without the need for costly lab visits.
At the heart of this innovation is a nanoporous anodic aluminum oxide (NAAO) substrate, layered with gold nanoparticles via air-water-oil interfacial self-assembly. This unique structure significantly enhances Raman signal detection, allowing for precise biomarker analysis from a small sample. A laser generator directs a beam onto the sample, where interaction with the NAAO substrate produces a scattered light signal. A highly sensitive light sensor then captures and analyzes this signal, providing critical health data in real-time.
One of the most remarkable features of this device is its adaptability. It is equipped with a bandpass filter and a beam splitter, allowing selective wavelength adjustments tailored to specific biomarkers. Whether detecting indicators of dementia, cancer, heart disease, or hormonal imbalances, this device provides an all-in-one solution for multi-biomarker screening. Additionally, an interactive display and Wi-Fi connectivity enable seamless data communication, ensuring users can track and interpret their health metrics with ease.
By merging high-performance spectroscopy with user-friendly design, MetGen’s handheld SERS device revolutionizes personal health monitoring. This game-changing technology not only enhances accessibility to critical diagnostics but also significantly reduces costs and time associated with traditional laboratory testing. With this advancement, MetGen is paving the way for a future where early disease detection is more accessible, efficient, and precise than ever before.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
